{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:23:22Z","timestamp":1779110602806,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05484-2","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T14:02:16Z","timestamp":1697551336000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictors of treatment failure of non-steroidal anti-inflammatory drugs in patients with axial spondyloarthritis with focus on haptoglobin, haptoglobin polymorphism and zonulin"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-9437","authenticated-orcid":false,"given":"Magdalena","family":"Chmieli\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-1061","authenticated-orcid":false,"given":"Marzena","family":"Olesi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-8225","authenticated-orcid":false,"given":"Anna","family":"Felis-Giemza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4249-3136","authenticated-orcid":false,"given":"Agnieszka","family":"Paradowska-Gorycka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1797-9800","authenticated-orcid":false,"given":"Karolina","family":"Palej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1708-4509","authenticated-orcid":false,"given":"Julita","family":"Rejmer-Szcze\u015bniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-060X","authenticated-orcid":false,"given":"Dariusz","family":"Szukiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"issue":"4","key":"5484_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","volume":"24","author":"C Ambarus","year":"2012","unstructured":"Ambarus C, Yeremenko N, Tak PP, Baeten D (2012) Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory. Curr Opin Rheumatol 24(4):351\u2013358. https:\/\/doi.org\/10.1097\/BOR.0b013e3283534df4","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"5484_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2040622317743486","volume":"9","author":"S Dubash","year":"2018","unstructured":"Dubash S, McGonagle D, Marzo-Ortega H (2018) New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice. Ther Adv Chronic Dis 9(3):77\u201387. https:\/\/doi.org\/10.1177\/2040622317743486","journal-title":"Ther Adv Chronic Dis"},{"issue":"372","key":"5484_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4447","volume":"4","author":"C Ritchlin","year":"2021","unstructured":"Ritchlin C, Adamopoulos IE (2021) Axial spondyloarthritis: new advances in diagnosis and management. BMJ 4(372):m4447. https:\/\/doi.org\/10.1136\/bmj.m4447. (PMID: 33397652)","journal-title":"BMJ"},{"key":"5484_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109332","volume":"251","author":"D Mauro","year":"2023","unstructured":"Mauro D, Srinath A, Guggino G, Nicolaidou V, Raimondo S, Ellis JJ, Whyte J, Nicoletti MM, Romano M, Kenna TJ, Ca\u00f1ete JD, Alessandro R, Rizzo A, Brown MA, Horwood NJ, Haroon N, Ciccia F (2023) Prostaglandin E2\/EP4 axis is upregulated in spondyloarthritis and contributes to radiographic progression. Clin Immunol (Orlando, Fla) 251:109332. https:\/\/doi.org\/10.1016\/j.clim.2023.109332","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"10","key":"5484_CR5","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German spondyloarthritis inception cohort. Ann Rheum Dis 71(10):1616\u20131622. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201252","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5484_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.41164","volume":"72","author":"R Wang","year":"2020","unstructured":"Wang R, Bathon JM, Ward MM (2020) Nonsteroidal antiinflammatory drugs as potential disease-modifying medications in axial spondyloarthritis. Arthritis Rheumatol (Hoboken, NJ) 72(4):518\u2013528. https:\/\/doi.org\/10.1002\/art.41164","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"1","key":"5484_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, G\u00e9her P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, L\u00f3pez-Medina C, van der Heijde D (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5484_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/ar4561","volume":"16","author":"PC Robinson","year":"2014","unstructured":"Robinson PC, Brown MA (2014) The window of opportunity: a relevant concept for axial spondyloarthritis. Arthritis Res Ther 16(3):109. https:\/\/doi.org\/10.1186\/ar4561","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"5484_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","volume":"42","author":"MR Langlois","year":"1996","unstructured":"Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589\u20131600","journal-title":"Clin Chem"},{"issue":"8","key":"5484_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.trstmh.2008.04.010","volume":"102","author":"IK Quaye","year":"2008","unstructured":"Quaye IK (2008) Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102(8):735\u2013742. https:\/\/doi.org\/10.1016\/j.trstmh.2008.04.010","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1\u20132","key":"5484_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cccn.2004.03.0","volume":"345","author":"H Van Vlierberghe","year":"2004","unstructured":"Van Vlierberghe H, Langlois M, Delanghe J (2004) Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta Int J Clin Chem 345(1\u20132):35\u201342. https:\/\/doi.org\/10.1016\/j.cccn.2004.03.0","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"39","key":"5484_CR12","doi-asserted-by":"publisher","first-page":"16799","DOI":"10.1073\/pnas.0906773106","volume":"106","author":"A Tripathi","year":"2009","unstructured":"Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, Arrietta MC, Meddings JB, Fasano A (2009) Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA 106(39):16799\u201316804. https:\/\/doi.org\/10.1073\/pnas.0906773106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"5484_CR13","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1136\/gutjnl-2020-323367","volume":"70","author":"A Fasano","year":"2021","unstructured":"Fasano A (2021) Zonulin measurement conundrum: add confusion to confusion does not lead to clarity. Gut 70(10):2007\u20132008. https:\/\/doi.org\/10.1136\/gutjnl-2020-323367","journal-title":"Gut"},{"issue":"6","key":"5484_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S, Saieva L, Cypers H, Stampone T, Di Benedetto P, Gabrielli A, Fasano A, Elewaut D, Triolo G (2017) Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis 76(6):1123\u20131132. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210000","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"5484_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey E, Vereecke L, McGovern D, Fr\u00f6hling M, Schett G, Danese S, De Vos M, Van den Bosch F, Elewaut D (2020) Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol 16(8):415\u2013433. https:\/\/doi.org\/10.1038\/s41584-020-0454-9","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5484_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","volume":"72","author":"L Van Praet","year":"2013","unstructured":"Van Praet L, Van den Bosch FE, Jacques P, Carron P, Jans L, Colman R, Glorieus E, Peeters H, Mielants H, De Vos M, Cuvelier C, Elewaut D (2013) Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 72(3):414\u2013417. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202135","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5484_CR17","first-page":"2279","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Gyselbrecht L, Elewaut D (1995) The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 22(12):2279\u20132284","journal-title":"J Rheumatol"},{"issue":"5","key":"5484_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/jcm10051131","volume":"10","author":"M Chmieli\u0144ska","year":"2021","unstructured":"Chmieli\u0144ska M, Olesi\u0144ska M, Romanowska-Pr\u00f3chnicka K, Szukiewicz D (2021) Haptoglobin and its related protein, zonulin\u2014what is their role in spondyloarthropathy? J Clin Med 10(5):1131. https:\/\/doi.org\/10.3390\/jcm10051131","journal-title":"J Clin Med"},{"issue":"2","key":"5484_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Metter A, Listing J, Sieper J, Braun J (2006) Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54(2):569\u2013578. https:\/\/doi.org\/10.1002\/art.21619","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5484_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S\u00f8rensen IJ, Ozgocmen S, Roussou E, Valle-O\u00f1ate R, Sieper J (2009) The development of Assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"5484_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cca.2014.02.029","volume":"433","author":"M Soejima","year":"2014","unstructured":"Soejima M, Sagata N, Komatsu N, Sasada T, Kawaguchi A, Itoh K, Koda Y (2014) Genetic factors associated with serum haptoglobin level in a Japanese population. Clin Chim Acta Int J Clin Chem 433:54\u201357. https:\/\/doi.org\/10.1016\/j.cca.2014.02.029","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"9","key":"5484_CR22","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00256-022-04018-4","volume":"51","author":"T Diekhoff","year":"2022","unstructured":"Diekhoff T, Lambert R, Hermann KG (2022) MRI in axial spondyloarthritis: understanding an \u201cASAS-positive MRI\u201d and the ASAS classification criteria. Skeletal Radiol 51(9):1721\u20131730. https:\/\/doi.org\/10.1007\/s00256-022-04018-4","journal-title":"Skeletal Radiol"},{"issue":"Suppl 2","key":"5484_CR23","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landew\u00e9 R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013ii44. https:\/\/doi.org\/10.1136\/ard.2008.104018","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5484_CR24","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"1","key":"5484_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper J, Lenaerts J, Wollenhaupt J, Rudwaleit M, Mazurov VI, Myasoutova L, Park S, Song Y, Yao R, Chitkara D, Vastesaeger N, Investigators AINFAST (2014) Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Ann Rheum Dis 73(1):101\u2013107. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203201","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5484_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/ard-2022-223297","volume":"82","author":"A Ortolan","year":"2023","unstructured":"Ortolan A, Webers C, Sepriano A, Falzon L, Baraliakos X, Landew\u00e9 RB, Ramiro S, van der Heijde D, Nikiphorou E (2023) Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis 82(1):142\u2013152. https:\/\/doi.org\/10.1136\/ard-2022-223297","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5484_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/rheumatology\/kew367","volume":"56","author":"X Baraliakos","year":"2017","unstructured":"Baraliakos X, Kiltz U, Peters S, Appel H, Dybowski F, Igelmann M, Kalthoff L, Krause D, Menne HJ, Saracbasi-Zender E, Schmitz-Bortz E, Vigneswaran M, Braun J (2017) Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis. Rheumatology (Oxford) 56(1):95\u2013102. https:\/\/doi.org\/10.1093\/rheumatology\/kew367","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"5484_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.40866","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landew\u00e9 R, Rudwaleit M, Hall S, Bauer L, Hoepken B, de Peyrecave N, Kilgallen B, van der Heijde D (2019) A fifty-two-week, randomized, placebo-controlled trial of certolizumab pegol in nonradiographic axial spondyloarthritis. Arthritis Rheumatol (Hoboken, NJ) 71(7):1101\u20131111. https:\/\/doi.org\/10.1002\/art.40866","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"11","key":"5484_CR29","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/rheumatology\/kew230","volume":"55","author":"J Sieper","year":"2016","unstructured":"Sieper J, Rudwaleit M, Lenaerts J, Wollenhaupt J, Myasoutova L, Park SH, Song YW, Yao R, Huyck S, Govoni M, Chitkara D, Vastesaeger N (2016) Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics. Rheumatology (Oxford) 55(11):1946\u20131953. https:\/\/doi.org\/10.1093\/rheumatology\/kew230","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"5484_CR30","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/rheumatology\/keh713","volume":"44","author":"N Barkham","year":"2005","unstructured":"Barkham N, Kong KO, Tennant A, Fraser A, Hensor E, Keenan AM, Emery P (2005) The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology (Oxford) 44(10):1277\u20131281. https:\/\/doi.org\/10.1093\/rheumatology\/keh713","journal-title":"Rheumatology (Oxford)"},{"key":"5484_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.12688\/f1000research.20510.1","volume":"9","author":"A Fasano","year":"2020","unstructured":"Fasano A (2020) All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research 9:69. https:\/\/doi.org\/10.12688\/f1000research.20510.1","journal-title":"F1000Research"},{"issue":"1","key":"5484_CR32","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik N, Frech M, Schulz O, Sch\u00e4lter F, Lucas S, Azizov V, D\u00fcrholz K, Steffen F, Omata Y, Rings A, Bertog M, Rizzo A, Iljazovic A, Basic M, Kleyer A, Culemann S, Kr\u00f6nke G, Luo Y, \u00dcberla K, Gaipl US, Zaiss MM (2020) Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun 11(1):1995. https:\/\/doi.org\/10.1038\/s41467-020-15831-7","journal-title":"Nat Commun"},{"issue":"1","key":"5484_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/BOR.0000000000000239","volume":"28","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Rizzo A, Triolo G (2016) Subclinical gut inflammation in ankylosing spondylitis. Curr Opin Rheumatol 28(1):89\u201396. https:\/\/doi.org\/10.1097\/BOR.0000000000000239","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"5484_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/BOR.0000000000000070","volume":"26","author":"H Cypers","year":"2014","unstructured":"Cypers H, Van Praet L, Varkas G, Elewaut D (2014) Relevance of the gut\/joint axis for the management of spondyloarthritis in daily clinical practice. Curr Opin Rheumatol 26(4):371\u2013376. https:\/\/doi.org\/10.1097\/BOR.0000000000000070","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"5484_CR35","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"JJ Anderson","year":"2001","unstructured":"Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44(8):1876\u20131886. https:\/\/doi.org\/10.1002\/1529-0131(200108)44:8%3c1876::AID-ART326%3e3.0.CO;2-F. (PMID: 11508441)","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5484_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13075-016-1200-1","volume":"18","author":"RD Inman","year":"2016","unstructured":"Inman RD, Baraliakos X, Hermann KA, Braun J, Deodhar A, van der Heijde D, Xu S, Hsu B (2016) Serum biomarkers and changes in clinical\/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study. Arthritis Res Ther 18(1):304. https:\/\/doi.org\/10.1186\/s13075-016-1200-1","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5484_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/ard.50.3.154","volume":"50","author":"TL Reynolds","year":"1991","unstructured":"Reynolds TL, Khan MA, van der Linden S, Cleveland RP (1991) Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin. Ann Rheum Dis 50(3):154\u2013157. https:\/\/doi.org\/10.1136\/ard.50.3.154","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5484_CR38","first-page":"363","volume":"16","author":"A Filipowicz-Sosnowska","year":"1978","unstructured":"Filipowicz-Sosnowska A, Miko\u0142ajew M, Garwolinska H, Sadowska-Wr\u00f3blewska M (1978) Przydatno\u015bc okre\u015blenia poziomu haptoglobiny jako wska\u017anika aktywno\u015bci procesu zapalnego w surowicy chorych na zesztywniajace zapalenie staw\u00f3w kregos\u0142upa [Usefulness of serum haptoglobin level determinations as an indicator of the activity of the inflammatory process in patients with ankylosing spondylitis]. Reumatologia 16(3):363\u2013368","journal-title":"Reumatologia"},{"issue":"5","key":"5484_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/art.20174","volume":"50","author":"D Baeten","year":"2004","unstructured":"Baeten D, M\u00f8ller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F (2004) Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum 50(5):1611\u20131623. https:\/\/doi.org\/10.1002\/art.20174","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5484_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/ard.2010.133488","volume":"70","author":"M Dougados","year":"2011","unstructured":"Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, van der Heijde D (2011) ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 70(2):249\u2013251. https:\/\/doi.org\/10.1136\/ard.2010.133488","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05484-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:02:58Z","timestamp":1707933778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05484-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5484"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05484-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Magdalena Chmieli\u0144ska, Marzena Olesi\u0144ska, Anna Felis-Giemza, Agnieszka Paradowska-Gorycka, Karolina Palej, Julita Rejmer-Szcze\u015bniak and Dariusz Szukiewicz declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Bioethics Committee at the National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw (Date: 23 October 2020; No KBT-5\/1\/2020). All patients who participated in the study signed an informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}